A medical practice for treatment of spine/musculoskeletal pain, injury and disability with a special interest and expertise in Regenerative Medicine.
Paul Mayes, M.D. is classically trained as a Board Certified Physical Medicine and Rehabilitation / Pain physician, and successfully completed an American College of Graduate Medical Education (ACGME) certified anesthesia pain fellowship. His new medical practice for the treatment of spine / musculoskeletal pain, injury and disability with a special interest and expertise in Regenerative Medicine located in Conroe, Texas.
Extremely safe and effective treatment to address the root cause of pain, Regenerative Injection Therapy (RIT) renews the body’s own natural healing processes. The aim of the RIT stimulus is to initiate a series of events that result in purposeful high-grade inflammation and remodeling of a particular area of injury. The intended purpose of this process is to ultimately strengthen joints, muscles, tendons, and ligaments resulting in a stable, less painful structure. This possibility makes RIT a viable alternative to surgery, chronic medication therapy, or pain procedures designed to mask pain, rather than addressing the root cause. An example of palliative pain procedure is cortisone injections, which are known to be potentially harmful to joint and connective tissue health.
Regenerative Injection Therapy is affordable and cost effective. While medical insurance does not currently cover the cost of RIT, the cost of a basic treatment ranges from $150 to $300, depending on the body part and complexity of treatment. Multiple treatments may be necessary to obtain a satisfactory resolution of symptoms, and happily, RIT enjoys a high success rate. The treatment does not require complex aftercare or long periods of inactivity that might interfere with daily life.
The most common agents employed today in basic RIT preparations include dextrose, sodium morrhuate, P2G (phenol-glycerine-glucose) and lidocaine. Discoveries in the field of cell biology have led to the use of amended cellular products for RIT, platelet rich plasma being a prime example. Bone marrow concentrate and fat vascular fraction grafts are two others. The enhanced properties of current RIT treatment have changed the way it is viewed as a therapy option. No longer is RIT considered just an alternative or complimentary treatment choice, but rather a popular potential first line therapy.
Why Consider Regenerative Injection Therapy (RIT)? And who is a candidate?
• Current treatment course has failed.
• Advised that the next step is surgery, or you are not a candidate for surgery.
• RIT does not preclude surgery down the road, if it becomes necessary.
•Desire not to depend on opioid or nonsteroidal anti-inflammatory drugs (NSAIDS) for chronic pain relief.
•Concerned about the costs or potential adverse effects of other treatment options.
•Almost any painful musculoskeletal condition is a candidate for RIT.
For more information on the web, search the terms regenerative injection therapy, prolotherapy, sclerotherapy, platelet rich plasma and mesenchymal stem cells for orthopedic use.
Specific recommended sites include: getprolo.com and AAOMED.org.
